BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37098808)

  • 1. The role and molecular mechanism of metabolic reprogramming of colorectal cancer by UBR5 through PYK2 regulation of OXPHOS expression study.
    Qin R; Huang Y; Yao Y; Wang L; Zhang Z; Huang W; Su Y; Zhang Y; Guan A; Wang H
    J Biochem Mol Toxicol; 2023 Aug; 37(8):e23376. PubMed ID: 37098808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UBR5 Contributes to Colorectal Cancer Progression by Destabilizing the Tumor Suppressor ECRG4.
    Wang J; Zhao X; Jin L; Wu G; Yang Y
    Dig Dis Sci; 2017 Oct; 62(10):2781-2789. PubMed ID: 28856538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor cell-derived SPON2 promotes M2-polarized tumor-associated macrophage infiltration and cancer progression by activating PYK2 in CRC.
    Huang C; Ou R; Chen X; Zhang Y; Li J; Liang Y; Zhu X; Liu L; Li M; Lin D; Qiu J; Liu G; Zhang L; Wu Y; Tang H; Liu Y; Liang L; Ding Y; Liao W
    J Exp Clin Cancer Res; 2021 Sep; 40(1):304. PubMed ID: 34583750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UBR5 regulates proliferation and radiosensitivity in human laryngeal carcinoma via the p38/MAPK signaling pathway.
    Wang K; Tang J; Liu X; Wang Y; Chen W; Zheng R
    Oncol Rep; 2020 Aug; 44(2):685-697. PubMed ID: 32468011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UBR5 promotes cell proliferation and inhibits apoptosis in colon cancer by destablizing P21.
    Ji SQ; Zhang YX; Yang BH
    Pharmazie; 2017 Jul; 72(7):408-413. PubMed ID: 29441938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOCS3 expression is inversely correlated with Pyk2 in non-small cell lung cancer and exogenous SOCS3 inhibits proliferation and invasion of A549 cells.
    Zhang S; Wang W; Wang E; Qiu X
    Pathology; 2012 Aug; 44(5):434-40. PubMed ID: 22722483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of the E3 ubiquitin protein UBR5 as an oncogene and a prognostic biomarker in colorectal cancer.
    Xie Z; Liang H; Wang J; Xu X; Zhu Y; Guo A; Shen X; Cao F; Chang W
    Oncotarget; 2017 Dec; 8(64):108079-108092. PubMed ID: 29296225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyk2 inhibition of p53 as an adaptive and intrinsic mechanism facilitating cell proliferation and survival.
    Lim ST; Miller NL; Nam JO; Chen XL; Lim Y; Schlaepfer DD
    J Biol Chem; 2010 Jan; 285(3):1743-53. PubMed ID: 19880522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E3 ubiquitin ligase UBR5 promotes pancreatic cancer growth and aerobic glycolysis by downregulating FBP1 via destabilization of C/EBPα.
    Chen L; Yuan R; Wen C; Liu T; Feng Q; Deng X; Du Y; Peng X
    Oncogene; 2021 Jan; 40(2):262-276. PubMed ID: 33122826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The E3 ligase UBR5 regulates gastric cancer cell growth by destabilizing the tumor suppressor GKN1.
    Yang M; Jiang N; Cao QW; Ma MQ; Sun Q
    Biochem Biophys Res Commun; 2016 Sep; 478(4):1624-9. PubMed ID: 27590582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UBR5 inhibits the radiosensitivity of non-small cell lung cancer cells via the activation of the PI3K/AKT pathway.
    Gu YF; Ge XP
    J Investig Med; 2021 Jun; 69(5):970-975. PubMed ID: 33811132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UBR-box containing protein, UBR5, is over-expressed in human lung adenocarcinoma and is a potential therapeutic target.
    Saurabh K; Shah PP; Doll MA; Siskind LJ; Beverly LJ
    BMC Cancer; 2020 Aug; 20(1):824. PubMed ID: 32867711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-887-3p Inhibits the Progression of Colorectal Cancer via Downregulating DNMT1 Expression and Regulating P53 Expression.
    Teng D; Xia S; Hu S; Yan Y; Liu B; Yang Y; Du X
    Comput Intell Neurosci; 2022; 2022():7179733. PubMed ID: 35795731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone Demethylase JMJD2D Interacts With β-Catenin to Induce Transcription and Activate Colorectal Cancer Cell Proliferation and Tumor Growth in Mice.
    Peng K; Kou L; Yu L; Bai C; Li M; Mo P; Li W; Yu C
    Gastroenterology; 2019 Mar; 156(4):1112-1126. PubMed ID: 30472235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UBR5 promotes migration and invasion of glioma cells by regulating the ECRG4/NF-ҡB pathway.
    Wu Q; Liu L; Feng Y; Wang L; Liu X; Li Y
    J Biosci; 2022; 47():. PubMed ID: 36226349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA214 expression inhibits HCC cell proliferation through PTK2b/ Pyk2.
    Chen C; Tao Z; Li Y; Li J; Xu Y
    Cell Mol Biol (Noisy-le-grand); 2022 May; 68(1):20-25. PubMed ID: 35809332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UBR5 over-expression contributes to poor prognosis and tamoxifen resistance of ERa+ breast cancer by stabilizing β-catenin.
    Yang Y; Zhao J; Mao Y; Lin G; Li F; Jiang Z
    Breast Cancer Res Treat; 2020 Dec; 184(3):699-710. PubMed ID: 32914356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA hsa_circRNA_102209 promotes the growth and metastasis of colorectal cancer through miR-761-mediated Ras and Rab interactor 1 signaling.
    Li C; Zhou H
    Cancer Med; 2020 Sep; 9(18):6710-6725. PubMed ID: 32706154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
    Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long Non-Coding RNA SH3PXD2A-AS1 Promotes Cell Progression Partly Through Epigenetic Silencing P57 and KLF2 in Colorectal Cancer.
    Ma Z; Peng P; Zhou J; Hui B; Ji H; Wang J; Wang K
    Cell Physiol Biochem; 2018; 46(6):2197-2214. PubMed ID: 29734178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.